Status:
COMPLETED
Effects of Octanoic Acid for Treatment of Essential Voice Tremor
Lead Sponsor:
Syracuse University
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Essential Voice Tremor
Vocal Tremor
Eligibility:
All Genders
21+ years
Phase:
PHASE1
PHASE2
Brief Summary
Essential voice tremor is a neurological condition that produces a regular, shaking quality in the voice. One form of drug treatment that produces some improvement in tremor of the hands is octanoic a...
Detailed Description
Background: * Essential tremor of the voice produces regular shaking and hoarseness in the voice, making it difficult speech difficult to understand * Several previous studies have found that octanoi...
Eligibility Criteria
Inclusion
- Participants have a diagnosis of essential voice tremor and show signs of tremor during the endoscopy examination (when pictures of the voice box are obtained)during screening appointment
- Participants show measurable voice tremor from recordings of the voice during screening appointment
Exclusion
- Participants have a diagnosis or show signs of Parkinson's Disease or another non-essential tremor movement disorder
- Participants have a diagnosis or show signs of spasmodic dysphonia (a different neurological voice disorder)
- Participants have a diagnosis of a severe, non-stable medical condition, such as kidney or liver failure, severe heart disease, severe lung disease, severe metabolic disease, uncontrolled hyperthyroidism, or other life-threatening disease such as active cancer
- Participants have a diagnosis of diabetes mellitus
- Participants are unable to suspend/stop a medication that they are currently taking for tremor or voice disorder for 12 weeks to complete this study
- Participants have a dependence on alcohol or allergy to alcohol
- Participants are pregnant or lactating
- Participants have an allergy to soy
- Participants have Irritable Bowel Syndrome
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2017
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT01864525
Start Date
July 1 2013
End Date
March 31 2017
Last Update
August 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Syracuse University & Upstate Medical University
Syracuse, New York, United States, 13210